IFP Advisors’s VolitionRx Ltd VNRX Stock Holding History

IFP Advisors’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$68	–	3256
2021 Q1	$0	Hold	1	–	–	﹤0.01%	3240
2020 Q4	$0	Hold	1	–	–	﹤0.01%	3106
2020 Q3	$0	Buy	+1	New	+$68	﹤0.01%	3011

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's VNRX Position: Q2 2021 in Review

IFP Advisors sold out of VolitionRx Ltd (VNRX) in Q2 2021, closing a stake of 1 share — an estimated $68 sold.

IFP Advisors first reported a position in VNRX in Q3 2020 and held it in 3 quarters. The position peaked at $0 in Q1 2021. 46 funds tracked by Wall St. Rank hold VNRX as of Q2 2021.

IFP Advisors reported no remaining VolitionRx Ltd position as of Q2 2021 after selling out during the quarter.
IFP Advisors sold 1 VolitionRx Ltd share in Q2 2021, an estimated $68.
IFP Advisors first reported a position in VolitionRx Ltd in Q3 2020 and held it in 3 quarters.
IFP Advisors's VolitionRx Ltd position peaked at $0 in Q1 2021.
46 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2021.

Based on IFP Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.